1-6 of 6
Raoul Tibes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas

Esteban Braggio, Scott Van Wier, Juhi Ojha, Ellen McPhail, Yan W. Asmann, Jan Egan, Jackline Ayres da Silva, David Schiff, M. Beatriz Lopes, Paul A. Decker, Riccardo Valdez, Raoul Tibes, Bruce Eckloff, Thomas E. Witzig, A. Keith Stewart, Rafael Fonseca, Brian Patrick O'Neill
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (17): 3986–3994.
DOI: https://doi.org/10.1158/1078-0432.CCR-14-2116
Published: 31 August 2015
View article
PDF
Includes: Supplementary data
Journal Articles

Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors

Antonio Jimeno, Glen J. Weiss, Wilson H. Miller, Jr, Scott Gettinger, Bernard J.C. Eigl, Anne Lynne S. Chang, Joi Dunbar, Shannon Devens, Kerrie Faia, Georgios Skliris, Jeff Kutok, Karl D. Lewis, Raoul Tibes, William H. Sharfman, Robert W. Ross, Charles M. Rudin
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (10): 2766–2774.
DOI: https://doi.org/10.1158/1078-0432.CCR-12-3654
Published: 12 May 2013
View article
PDF
Journal Articles

A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors

Gayle S. Jameson, John T. Hamm, Glen J. Weiss, Carlos Alemany, Stephen Anthony, Michele Basche, Ramesh K. Ramanathan, Mitesh J. Borad, Raoul Tibes, Allen Cohn, Ioana Hinshaw, Robert Jotte, Lee S. Rosen, Ute Hoch, Michael A. Eldon, Robert Medve, Katrina Schroeder, Erica White, Daniel D. Von Hoff
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (1): 268–278.
DOI: https://doi.org/10.1158/1078-0432.CCR-12-1201
Published: 02 January 2013
View article
PDF
Journal Articles

Phase I Studies of CBP501, a G2 Checkpoint Abrogator, as Monotherapy and in Combination with Cisplatin in Patients with Advanced Solid Tumors

Geoffrey I. Shapiro, Raoul Tibes, Michael S. Gordon, Bryan Y. Wong, Joseph Paul Eder, Mitesh J. Borad, David S. Mendelson, Nicholas J. Vogelzang, Bruno R. Bastos, Glen J. Weiss, Cristian Fernandez, William Sutherland, Hitoshi Sato, William E. Pierceall, David Weaver, Scott Slough, Ernesto Wasserman, Donald W. Kufe, Daniel Von Hoff, Takumi Kawabe, Sunil Sharma
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (10): 3431–3442.
DOI: https://doi.org/10.1158/1078-0432.CCR-10-2345
Published: 15 May 2011
View article
PDF
Includes: Supplementary data
Journal Articles

Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of TH-302, a Hypoxia-Activated Prodrug, in Patients with Advanced Solid Malignancies

Glen J. Weiss, Jeffrey R. Infante, E. Gabriela Chiorean, Mitesh J. Borad, Johanna C. Bendell, Julian R. Molina, Raoul Tibes, Ramesh K. Ramanathan, Karen Lewandowski, Suzanne F. Jones, Mario E. Lacouture, Virginia K. Langmuir, Hank Lee, Stew Kroll, Howard A. Burris, III
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (9): 2997–3004.
DOI: https://doi.org/10.1158/1078-0432.CCR-10-3425
Published: 01 May 2011
View article
PDF
Includes: Supplementary data
Journal Articles

Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors

Patricia M. LoRusso, Charles M. Rudin, Josina C. Reddy, Raoul Tibes, Glen J. Weiss, Mitesh J. Borad, Christine L. Hann, Julie R. Brahmer, Ilsung Chang, Walter C. Darbonne, Richard A. Graham, Kenn L. Zerivitz, Jennifer A. Low, Daniel D. Von Hoff
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2502–2511.
DOI: https://doi.org/10.1158/1078-0432.CCR-10-2745
Published: 14 April 2011
View article
PDF
Includes: Supplementary data